Integration of optimized substituent patterns to produce highly potent 4-aryl-pyridine glucagon receptor antagonists

Optimized substituent patterns in 4-aryl-pyridine glucagon receptor antagonists were merged to produce highly potent derivatives containing both a 3-[(1 R)-hydroxyethyl] and a 2′-hydroxy group. Due to restricted rotation of the phenyl–pyridine bond, these analogues exist as four isomers. A diastereo...

Full description

Saved in:
Bibliographic Details
Published inBioorganic & medicinal chemistry letters Vol. 12; no. 23; pp. 3421 - 3424
Main Authors Ladouceur, Gaetan H., Cook, James H., Hertzog, Donald L., Jones, J.Howard, Hundertmark, Thomas, Korpusik, Mary, Lease, Timothy G., Livingston, James N., MacDougall, Margit L., Osterhout, Martin H., Phelan, Kathleen, Romero, Romulo H., Schoen, William R., Shao, Chunning, Smith, Roger A.
Format Journal Article
LanguageEnglish
Published Oxford Elsevier Ltd 02.12.2002
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Optimized substituent patterns in 4-aryl-pyridine glucagon receptor antagonists were merged to produce highly potent derivatives containing both a 3-[(1 R)-hydroxyethyl] and a 2′-hydroxy group. Due to restricted rotation of the phenyl–pyridine bond, these analogues exist as four isomers. A diastereoselective methylcopper reaction was developed to facilitate the synthesis, and single isomers were isolated with activities in the range IC 50=10–25 nM. Optimized substituent patterns in 4-aryl-pyridine glucagon receptor antagonists were merged to produce highly potent derivatives containing both a 3-[(1 R)-hydroxyethyl] and a 2′-hydroxy group. Due to restricted rotation of the phenyl–pyridine bond, these analogues exist as four isomers. A diastereoselective methylcopper reaction was developed to facilitate the synthesis, and single isomers were isolated with activities in the range IC 50=10–25 nM.
ISSN:0960-894X
1464-3405
DOI:10.1016/S0960-894X(02)00736-9